JNJ dips moderately
JNJ is down moderately on the day with low volatility, tracking slightly worse than the broad market's modest decline, and a media personality's dip-buying commentary hasn't sparked meaningful buying interest.
Sources: https://247wallst.com/investing/2026/09/08/cramer-says-its-time-to-buy-the-dip-on-jnj/
Previous verdicts for JNJ
- AI Search: JNJ edges higher as ICOTYDE psoriasis data outweighs guidance cut — 2026-10-07
- JNJ Drifts Lower Quietly — 2026-10-01
- Muted Trial Reaction — 2026-09-21
- JNJ drifts higher quietly — 2026-09-18
- JNJ Slips Sharply — 2026-09-10
Sources
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works